830 research outputs found
Redfining the boundaries of drug-eluting stent utilization: from in-stent restenosis to acute myocardial infarction
Redfining the boundaries of drug-eluting stent utilization: from in-stent restenosis to acute myocardial infarction
Morpho-agronomic and genetic diversity among twelve Sicilian agro-ecotypes of lentil (Lens culinaris)
Although Sicily is relatively small (about 25000 km2), it accounts for several agro-ecotypes of lentil (Lens culinaris Medik.), for many of which no data on morphological, agronomic, and organoleptic characteristics are available to date. Thus, experiments were performed to characterize 12 lentil agro-ecotypes from different areas of Sicily, including some small islands surrounding the main island, and to assess the extent of genetic diversity (by means of six inter-simple sequence repeat [ISSR] primers). A famous agro-ecotype from central Italy (CastellucciodiNorcia) and two commercial varieties from Canada (Eston and Laird) were also included in the study. The results showed a large degree of genetic diversity (based on ISSR markers) and variability in pheno-morphological and agronomic traits. In contrast, the intra-accession variability was on average rather low. The agronomic (productivity, nitrogen fixation capacity) and qualitative (lipid content, hydration coefficient) attributes of several Sicilian agro-ecotypes were more pronounced than those of the controls. This fact certainly represents a prerequisite for their future economic valorization. Moreover, the observed variability may be of interest from the point of view of breeding
Shimura curve Atkin--Lehner quotients of genus at most two
We provide a complete enumeration of all quotients of genus and of the Shimura curves over by non-trivial subgroups of Atkin--Lehner involutions. For all genus quotients with squarefree, we determine the isomorphism class of the Jacobian . For non-elliptic genus curves and for curves genus quotients , we provide a defining equation for . A main tool for us is the theory of Čerednik--Drinfeld uniformizations of the curves , which we implement in wider generality than has previously been done in the literature
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)
peer reviewedMild renal impairment is an important risk factor for late cardiovascular complications. This substudy of the Lescol Intervention Prevention Study (LIPS) assessed the effect of fluvastatin on outcome of patients who had renal dysfunction and those who did not. Complete data for creatinine clearance calculation. (Cockcroft=Gault formula) were available for 1,558 patients (92.9% of the LIPS population). Patients were randomized to fluvastatin or placebo after successful completion of a first percutaneous coronary intervention. Follow-up time was, 3 to 4 years. The effect of baseline creatinine clearance on coronary atherosclerotic events (cardiac death, non-fatal myocardial infarction, and coronary reinterventions not related to restenosis) was evaluated. Baseline creatinine clearance (logarithmic transformation) was inversely associated with an incidence of adverse events among patients who received, placebo. (hazard ratio 0.99, 95% confidence interval 0.982 to 0.998, p = 0.01). However, no association was noted between creatinine clearance and the incidence of adverse events among patients who received fluvastatin (hazard ratio 1.0, 95% confidence interval 0.99 to 1.0, p = 0.63). No further deterioration in creatinine clearance was observed during follow-up; regardless of baseline renal function or allocated treatment. Occurrence of adverse events was not related to changes in renal function during follow-up. Fluvastatin therapy markedly decreased the risk of coronary atherosclerotic events after percutaneous intervention in: patients who had lower values of creatinine clearance at baseline: The benefit of fluvastatin was unrelated to any effect on renal function. (C) 2005 by Excerpta Medica Inc
Redfining the boundaries of drug-eluting stent utilization: from in-stent restenosis to acute myocardial infarction
- …
